{"entity":{"type":"insider","cik":"0001786304","url":"/insider/0001786304","json_url":"/insider/0001786304.json","name":"Evans John M.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":103,"n_filings":23,"first":"2021-01-04","last":"2026-07-01","span_basis":"filed_date"},"name_variants":[{"name":"Evans John M.","source":"filing","n_filings":23,"first_seen":"2021-01-04","last_seen":"2026-07-01"}],"transactions":[{"id":6063266,"accession":"0001193125-26-292526","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001193125-26-292526","line_url":"/filing/0001193125-26-292526#line-7","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23100.0,"shares_display":"23,100","price_per_share":34.2633,"price_display":"34.26","price_state":"stated","total_value":791482.23,"total_display":"791,482.23","shares_owned_after":1049105.0,"shares_owned_after_display":"1,049,105","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-30","filed_date":"2026-07-01","scope":"insider"},{"id":6063264,"accession":"0001193125-26-292526","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193125-26-292526","line_url":"/filing/0001193125-26-292526#line-6","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":34.8437,"price_display":"34.84","price_state":"stated","total_value":66203.03,"total_display":"66,203.03","shares_owned_after":1047205.0,"shares_owned_after_display":"1,047,205","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-30","filed_date":"2026-07-01","scope":"insider"},{"id":6063256,"accession":"0001193125-26-292526","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-292526","line_url":"/filing/0001193125-26-292526#line-4","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13421.0,"shares_display":"13,421","price_per_share":35.1336,"price_display":"35.13","price_state":"stated","total_value":471528.0456,"total_display":"471,528.05","shares_owned_after":1058784.0,"shares_owned_after_display":"1,058,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-29","filed_date":"2026-07-01","scope":"insider"},{"id":6063253,"accession":"0001193125-26-292526","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-292526","line_url":"/filing/0001193125-26-292526#line-3","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11579.0,"shares_display":"11,579","price_per_share":35.9119,"price_display":"35.91","price_state":"stated","total_value":415823.8901,"total_display":"415,823.89","shares_owned_after":1047205.0,"shares_owned_after_display":"1,047,205","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-29","filed_date":"2026-07-01","scope":"insider"},{"id":5785043,"accession":"0001193125-26-144086","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-144086","line_url":"/filing/0001193125-26-144086#line-1","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30078.0,"shares_display":"30,078","price_per_share":24.58,"price_display":"24.58","price_state":"stated","total_value":739317.24,"total_display":"739,317.24","shares_owned_after":1047205.0,"shares_owned_after_display":"1,047,205","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-01","filed_date":"2026-04-06","scope":"insider"},{"id":6016998,"accession":"0001193125-26-138348","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193125-26-138348","line_url":"/filing/0001193125-26-138348#line-5","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":22.7634,"price_display":"22.76","price_state":"stated","total_value":569085.0,"total_display":"569,085.00","shares_owned_after":986667.0,"shares_owned_after_display":"986,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-31","filed_date":"2026-04-01","scope":"insider"},{"id":6016990,"accession":"0001193125-26-138348","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-138348","line_url":"/filing/0001193125-26-138348#line-2","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":22.3692,"price_display":"22.37","price_state":"stated","total_value":559230.0,"total_display":"559,230.00","shares_owned_after":986667.0,"shares_owned_after_display":"986,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-30","filed_date":"2026-04-01","scope":"insider"},{"id":5836292,"accession":"0001193125-26-033600","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001193125-26-033600","line_url":"/filing/0001193125-26-033600#line-7","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22094.0,"shares_display":"22,094","price_per_share":28.2734,"price_display":"28.27","price_state":"stated","total_value":624672.4996,"total_display":"624,672.50","shares_owned_after":989573.0,"shares_owned_after_display":"989,573","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-30","filed_date":"2026-02-02","scope":"insider"},{"id":5836290,"accession":"0001193125-26-033600","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193125-26-033600","line_url":"/filing/0001193125-26-033600#line-6","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2906.0,"shares_display":"2,906","price_per_share":29.0,"price_display":"29.00","price_state":"stated","total_value":84274.0,"total_display":"84,274.00","shares_owned_after":986667.0,"shares_owned_after_display":"986,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-30","filed_date":"2026-02-02","scope":"insider"},{"id":5836286,"accession":"0001193125-26-033600","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-033600","line_url":"/filing/0001193125-26-033600#line-4","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16333.0,"shares_display":"16,333","price_per_share":29.1925,"price_display":"29.19","price_state":"stated","total_value":476801.1025,"total_display":"476,801.10","shares_owned_after":995334.0,"shares_owned_after_display":"995,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-29","filed_date":"2026-02-02","scope":"insider"},{"id":5836284,"accession":"0001193125-26-033600","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-033600","line_url":"/filing/0001193125-26-033600#line-3","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8667.0,"shares_display":"8,667","price_per_share":29.7428,"price_display":"29.74","price_state":"stated","total_value":257780.8476,"total_display":"257,780.85","shares_owned_after":986667.0,"shares_owned_after_display":"986,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-29","filed_date":"2026-02-02","scope":"insider"},{"id":4066275,"accession":"0001193125-25-230084","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-25-230084","line_url":"/filing/0001193125-25-230084#line-4","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":24.6267,"price_display":"24.63","price_state":"stated","total_value":615667.5,"total_display":"615,667.50","shares_owned_after":986667.0,"shares_owned_after_display":"986,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-03","scope":"insider"},{"id":4066269,"accession":"0001193125-25-230084","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-230084","line_url":"/filing/0001193125-25-230084#line-2","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":24.5062,"price_display":"24.51","price_state":"stated","total_value":612655.0,"total_display":"612,655.00","shares_owned_after":986667.0,"shares_owned_after_display":"986,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-01","filed_date":"2025-10-03","scope":"insider"},{"id":4791628,"accession":"0000950170-25-050857","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-050857","line_url":"/filing/0000950170-25-050857#line-1","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30663.0,"shares_display":"30,663","price_per_share":18.3506,"price_display":"18.35","price_state":"stated","total_value":562684.4478,"total_display":"562,684.45","shares_owned_after":986249.0,"shares_owned_after_display":"986,249","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-01","filed_date":"2025-04-03","scope":"insider"},{"id":4027190,"accession":"0000950170-25-012304","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-012304","line_url":"/filing/0000950170-25-012304#line-2","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29800.0,"shares_display":"29,800","price_per_share":26.7459,"price_display":"26.75","price_state":"stated","total_value":797027.82,"total_display":"797,027.82","shares_owned_after":908859.0,"shares_owned_after_display":"908,859","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-30","filed_date":"2025-02-03","scope":"insider"},{"id":4027189,"accession":"0000950170-25-012304","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-012304","line_url":"/filing/0000950170-25-012304#line-1","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":27.28,"price_display":"27.28","price_state":"stated","total_value":5456.0,"total_display":"5,456.00","shares_owned_after":908659.0,"shares_owned_after_display":"908,659","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-30","filed_date":"2025-02-03","scope":"insider"},{"id":2590489,"accession":"0000950170-24-111732","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-111732","line_url":"/filing/0000950170-24-111732#line-1","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":24.6004,"price_display":"24.60","price_state":"stated","total_value":1476024.0,"total_display":"1,476,024.00","shares_owned_after":938659.0,"shares_owned_after_display":"938,659","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-30","filed_date":"2024-10-02","scope":"insider"},{"id":2117142,"accession":"0000950170-24-079065","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-079065","line_url":"/filing/0000950170-24-079065#line-1","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":24.5026,"price_display":"24.50","price_state":"stated","total_value":1470156.0,"total_display":"1,470,156.00","shares_owned_after":998343.0,"shares_owned_after_display":"998,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-27","filed_date":"2024-06-28","scope":"insider"},{"id":2676225,"accession":"0000950170-24-041432","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-041432","line_url":"/filing/0000950170-24-041432#line-1","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18102.0,"shares_display":"18,102","price_per_share":32.13,"price_display":"32.13","price_state":"stated","total_value":581617.26,"total_display":"581,617.26","shares_owned_after":1058343.0,"shares_owned_after_display":"1,058,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider"},{"id":3151647,"accession":"0000950170-24-039319","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-039319","line_url":"/filing/0000950170-24-039319#line-1","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":33.8567,"price_display":"33.86","price_state":"stated","total_value":2031402.0,"total_display":"2,031,402.00","shares_owned_after":998262.0,"shares_owned_after_display":"998,262","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-28","filed_date":"2024-04-01","scope":"insider"},{"id":2733789,"accession":"0000950170-24-010477","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-010477","line_url":"/filing/0000950170-24-010477#line-1","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":25.33,"price_display":"25.33","price_state":"stated","total_value":1519800.0,"total_display":"1,519,800.00","shares_owned_after":1058262.0,"shares_owned_after_display":"1,058,262","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-31","filed_date":"2024-02-02","scope":"insider"},{"id":8598319,"accession":"0000899243-23-010819","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-010819","line_url":"/filing/0000899243-23-010819#line-2","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6493.0,"shares_display":"6,493","price_per_share":29.0935,"price_display":"29.09","price_state":"stated","total_value":188904.0955,"total_display":"188,904.10","shares_owned_after":1117979.0,"shares_owned_after_display":"1,117,979","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-04","filed_date":"2023-04-05","scope":"insider"},{"id":8598316,"accession":"0000899243-23-010819","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-010819","line_url":"/filing/0000899243-23-010819#line-1","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5161.0,"shares_display":"5,161","price_per_share":30.31,"price_display":"30.31","price_state":"stated","total_value":156429.91,"total_display":"156,429.91","shares_owned_after":1124472.0,"shares_owned_after_display":"1,124,472","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-05","scope":"insider"},{"id":6915164,"accession":"0000899243-22-034759","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-22-034759","line_url":"/filing/0000899243-22-034759#line-8","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11756.0,"shares_display":"11,756","price_per_share":46.8813,"price_display":"46.88","price_state":"stated","total_value":551136.5628,"total_display":"551,136.56","shares_owned_after":1061429.0,"shares_owned_after_display":"1,061,429","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-31","filed_date":"2022-11-02","scope":"insider"},{"id":6915160,"accession":"0000899243-22-034759","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-22-034759","line_url":"/filing/0000899243-22-034759#line-7","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8235.0,"shares_display":"8,235","price_per_share":46.9143,"price_display":"46.91","price_state":"stated","total_value":386339.2605,"total_display":"386,339.26","shares_owned_after":105188.0,"shares_owned_after_display":"105,188","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-31","filed_date":"2022-11-02","scope":"insider"},{"id":6915156,"accession":"0000899243-22-034759","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-22-034759","line_url":"/filing/0000899243-22-034759#line-6","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7768.0,"shares_display":"7,768","price_per_share":46.192,"price_display":"46.19","price_state":"stated","total_value":358819.456,"total_display":"358,819.46","shares_owned_after":1073185.0,"shares_owned_after_display":"1,073,185","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-31","filed_date":"2022-11-02","scope":"insider"},{"id":6915154,"accession":"0000899243-22-034759","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-034759","line_url":"/filing/0000899243-22-034759#line-5","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7567.0,"shares_display":"7,567","price_per_share":44.9246,"price_display":"44.92","price_state":"stated","total_value":339944.4482,"total_display":"339,944.45","shares_owned_after":1080953.0,"shares_owned_after_display":"1,080,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-31","filed_date":"2022-11-02","scope":"insider"},{"id":6915150,"accession":"0000899243-22-034759","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-034759","line_url":"/filing/0000899243-22-034759#line-4","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5008.0,"shares_display":"5,008","price_per_share":44.9268,"price_display":"44.93","price_state":"stated","total_value":224993.4144,"total_display":"224,993.41","shares_owned_after":117992.0,"shares_owned_after_display":"117,992","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-31","filed_date":"2022-11-02","scope":"insider"},{"id":6915146,"accession":"0000899243-22-034759","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-034759","line_url":"/filing/0000899243-22-034759#line-3","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4569.0,"shares_display":"4,569","price_per_share":46.1882,"price_display":"46.19","price_state":"stated","total_value":211033.8858,"total_display":"211,033.89","shares_owned_after":113423.0,"shares_owned_after_display":"113,423","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-31","filed_date":"2022-11-02","scope":"insider"},{"id":6915142,"accession":"0000899243-22-034759","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-034759","line_url":"/filing/0000899243-22-034759#line-2","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2909.0,"shares_display":"2,909","price_per_share":47.8944,"price_display":"47.89","price_state":"stated","total_value":139324.8096,"total_display":"139,324.81","shares_owned_after":1058520.0,"shares_owned_after_display":"1,058,520","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-31","filed_date":"2022-11-02","scope":"insider"},{"id":6915136,"accession":"0000899243-22-034759","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-034759","line_url":"/filing/0000899243-22-034759#line-1","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2188.0,"shares_display":"2,188","price_per_share":47.9143,"price_display":"47.91","price_state":"stated","total_value":104836.4884,"total_display":"104,836.49","shares_owned_after":103000.0,"shares_owned_after_display":"103,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-31","filed_date":"2022-11-02","scope":"insider"},{"id":6089613,"accession":"0000899243-22-027077","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-22-027077","line_url":"/filing/0000899243-22-027077#line-9","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15236.0,"shares_display":"15,236","price_per_share":65.8241,"price_display":"65.82","price_state":"stated","total_value":1002895.9876,"total_display":"1,002,895.99","shares_owned_after":1093103.0,"shares_owned_after_display":"1,093,103","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-28","filed_date":"2022-07-29","scope":"insider"},{"id":6089609,"accession":"0000899243-22-027077","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-22-027077","line_url":"/filing/0000899243-22-027077#line-8","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10599.0,"shares_display":"10,599","price_per_share":65.9188,"price_display":"65.92","price_state":"stated","total_value":698673.3612,"total_display":"698,673.36","shares_owned_after":125448.0,"shares_owned_after_display":"125,448","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-28","filed_date":"2022-07-29","scope":"insider"},{"id":6089606,"accession":"0000899243-22-027077","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-22-027077","line_url":"/filing/0000899243-22-027077#line-7","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10181.0,"shares_display":"10,181","price_per_share":64.8688,"price_display":"64.87","price_state":"stated","total_value":660429.2528,"total_display":"660,429.25","shares_owned_after":1108339.0,"shares_owned_after_display":"1,108,339","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-28","filed_date":"2022-07-29","scope":"insider"},{"id":6089604,"accession":"0000899243-22-027077","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-22-027077","line_url":"/filing/0000899243-22-027077#line-6","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6953.0,"shares_display":"6,953","price_per_share":64.8804,"price_display":"64.88","price_state":"stated","total_value":451113.4212,"total_display":"451,113.42","shares_owned_after":136047.0,"shares_owned_after_display":"136,047","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-28","filed_date":"2022-07-29","scope":"insider"},{"id":6089600,"accession":"0000899243-22-027077","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-027077","line_url":"/filing/0000899243-22-027077#line-5","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2848.0,"shares_display":"2,848","price_per_share":67.7996,"price_display":"67.80","price_state":"stated","total_value":193093.2608,"total_display":"193,093.26","shares_owned_after":1088693.0,"shares_owned_after_display":"1,088,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-28","filed_date":"2022-07-29","scope":"insider"},{"id":6089597,"accession":"0000899243-22-027077","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-027077","line_url":"/filing/0000899243-22-027077#line-4","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2247.0,"shares_display":"2,247","price_per_share":67.8163,"price_display":"67.82","price_state":"stated","total_value":152383.2261,"total_display":"152,383.23","shares_owned_after":123000.0,"shares_owned_after_display":"123,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-28","filed_date":"2022-07-29","scope":"insider"},{"id":6089594,"accession":"0000899243-22-027077","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-027077","line_url":"/filing/0000899243-22-027077#line-3","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1562.0,"shares_display":"1,562","price_per_share":66.7448,"price_display":"66.74","price_state":"stated","total_value":104255.3776,"total_display":"104,255.38","shares_owned_after":1091541.0,"shares_owned_after_display":"1,091,541","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-28","filed_date":"2022-07-29","scope":"insider"},{"id":6089591,"accession":"0000899243-22-027077","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-027077","line_url":"/filing/0000899243-22-027077#line-2","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":201.0,"shares_display":"201","price_per_share":66.6095,"price_display":"66.61","price_state":"stated","total_value":13388.5095,"total_display":"13,388.51","shares_owned_after":125247.0,"shares_owned_after_display":"125,247","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-28","filed_date":"2022-07-29","scope":"insider"},{"id":6089587,"accession":"0000899243-22-027077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-027077","line_url":"/filing/0000899243-22-027077#line-1","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":173.0,"shares_display":"173","price_per_share":68.49,"price_display":"68.49","price_state":"stated","total_value":11848.77,"total_display":"11,848.77","shares_owned_after":1088520.0,"shares_owned_after_display":"1,088,520","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-28","filed_date":"2022-07-29","scope":"insider"},{"id":6741135,"accession":"0000899243-22-016164","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000899243-22-016164","line_url":"/filing/0000899243-22-016164#line-12","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13655.0,"shares_display":"13,655","price_per_share":37.48,"price_display":"37.48","price_state":"stated","total_value":511789.4,"total_display":"511,789.40","shares_owned_after":1130965.0,"shares_owned_after_display":"1,130,965","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-28","filed_date":"2022-05-02","scope":"insider"},{"id":6741132,"accession":"0000899243-22-016164","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000899243-22-016164","line_url":"/filing/0000899243-22-016164#line-11","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7745.0,"shares_display":"7,745","price_per_share":37.84,"price_display":"37.84","price_state":"stated","total_value":293070.8,"total_display":"293,070.80","shares_owned_after":148805.0,"shares_owned_after_display":"148,805","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-28","filed_date":"2022-05-02","scope":"insider"},{"id":6741129,"accession":"0000899243-22-016164","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000899243-22-016164","line_url":"/filing/0000899243-22-016164#line-10","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6842.0,"shares_display":"6,842","price_per_share":38.32,"price_display":"38.32","price_state":"stated","total_value":262185.44,"total_display":"262,185.44","shares_owned_after":1124123.0,"shares_owned_after_display":"1,124,123","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-28","filed_date":"2022-05-02","scope":"insider"},{"id":6741127,"accession":"0000899243-22-016164","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-22-016164","line_url":"/filing/0000899243-22-016164#line-9","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6450.0,"shares_display":"6,450","price_per_share":36.98,"price_display":"36.98","price_state":"stated","total_value":238521.0,"total_display":"238,521.00","shares_owned_after":156550.0,"shares_owned_after_display":"156,550","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-28","filed_date":"2022-05-02","scope":"insider"},{"id":6741124,"accession":"0000899243-22-016164","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-22-016164","line_url":"/filing/0000899243-22-016164#line-8","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4503.0,"shares_display":"4,503","price_per_share":39.49,"price_display":"39.49","price_state":"stated","total_value":177823.47,"total_display":"177,823.47","shares_owned_after":1119620.0,"shares_owned_after_display":"1,119,620","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-28","filed_date":"2022-05-02","scope":"insider"},{"id":6741121,"accession":"0000899243-22-016164","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-22-016164","line_url":"/filing/0000899243-22-016164#line-7","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":36.59,"price_display":"36.59","price_state":"stated","total_value":142701.0,"total_display":"142,701.00","shares_owned_after":1144620.0,"shares_owned_after_display":"1,144,620","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-28","filed_date":"2022-05-02","scope":"insider"},{"id":6741118,"accession":"0000899243-22-016164","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-22-016164","line_url":"/filing/0000899243-22-016164#line-6","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":38.75,"price_display":"38.75","price_state":"stated","total_value":120125.0,"total_display":"120,125.00","shares_owned_after":145705.0,"shares_owned_after_display":"145,705","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-28","filed_date":"2022-05-02","scope":"insider"},{"id":6741115,"accession":"0000899243-22-016164","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-016164","line_url":"/filing/0000899243-22-016164#line-5","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2348.0,"shares_display":"2,348","price_per_share":39.73,"price_display":"39.73","price_state":"stated","total_value":93286.04,"total_display":"93,286.04","shares_owned_after":143357.0,"shares_owned_after_display":"143,357","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-28","filed_date":"2022-05-02","scope":"insider"},{"id":6741112,"accession":"0000899243-22-016164","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-016164","line_url":"/filing/0000899243-22-016164#line-4","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":40.73,"price_display":"40.73","price_state":"stated","total_value":44803.0,"total_display":"44,803.00","shares_owned_after":1118520.0,"shares_owned_after_display":"1,118,520","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-28","filed_date":"2022-05-02","scope":"insider"},{"id":6741109,"accession":"0000899243-22-016164","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-016164","line_url":"/filing/0000899243-22-016164#line-3","is_derivative":false,"issuer_cik":"0001745999","issuer_name":"Beam Therapeutics Inc.","issuer_ticker":"BEAM","issuer_name_source":null,"issuer_url":"/issuer/0001745999","owner_cik":"0001786304","owner_name":"Evans John M.","owner_url":"/insider/0001786304","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":357.0,"shares_display":"357","price_per_share":40.88,"price_display":"40.88","price_state":"stated","total_value":14594.16,"total_display":"14,594.16","shares_owned_after":143000.0,"shares_owned_after_display":"143,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-28","filed_date":"2022-05-02","scope":"insider"}],"next_cursor":"2022-04-28|6741109","ledger_fault":false,"count":{"value":103,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":103,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":103},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001745999","name":"Beam Therapeutics Inc.","url":"/issuer/0001745999","role":"Director, Officer (CEO)","n_filings":23,"first_seen":"2021-01-04","last_seen":"2026-07-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001786304","retrieved_at":"2026-08-21T17:08:22+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}